Patent ID: 6344203
Filing Date: 2002-02-05
Classification: A61K,A61P,C07K

Abstract:
A cancer vaccine for administration to a host comprising a peptide that binds to IB4 lectin and anti-Gal&agr;(1,3)Gal antibodies, and one or more pharmaceutically acceptable carrier or diluent, optionally in association with an appropriate carrier peptide or other therapeutic agent; wherein said peptide includes one or more of the following sequences:DAHWESWL (SEQ ID No. 1); DGHWANWV (SEQ ID No. 2); DGNWAIYV (SEQ ID No. 3); DADWAGFI (SEQ ID No. 4); DGHWDSWL (SEQ ID No. 5); VSTFDSWL (SEQ ID No. 6); GTSFDDWL (SEQ ID No. 7); and DLHWASWV (SEQ ID No. 8).